PlainPharmaWatch

CMS Open Payments · Program Year 2024

Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. reported $1,069,586.09 in payments to 10,833 physicians and teaching hospitals across 10,835 transactions.

See the rankings → How this is sourced
$1.1M
Total payments
10,835
Transactions
10,833
Recipients
+$709.2K
General Payments vs PY2023

Verrica Pharmaceuticals Inc. reported $1,069,586.09 in payments to 10,833 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #606 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $98.73 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Verrica Pharmaceuticals Inc. pairs above-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#606
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Verrica Pharmaceuticals Inc.'s CMS-reported General Payments increased by $709.2K (+201.9%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2023: VERRICA PHARMACEUTICALS INC.PY2024: Verrica Pharmaceuticals Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$351.3KPY2024$1.1M
PY2023
$351,322.54
PY2024
$1,060,498.44

How Verrica Pharmaceuticals Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Verrica Pharmaceuticals Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,069,586 Top 31% higher than 69% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Verrica Pharmaceuticals Inc.

In Program Year 2024, Verrica Pharmaceuticals Inc. reported $1,069,586.09 in payments to 10,833 physicians and teaching hospitals across 10,835 individual transactions, an average of $98.72 per transaction and $98.73 per recipient. That total places Verrica Pharmaceuticals Inc. at rank #606 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

238 transactions worth $605.5K make "Compensation for Services Other Than Consulting" the top general-payment category in the 5-category breakdown below, 56.6% of the reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Compensation for Services Other Than Consulting" leads Verrica Pharmaceuticals Inc.'s 5-category general-payment breakdown at $605.5K, 56.6% of the reported total.

How Verrica Pharmaceuticals Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$605.5K2. Food and Beverage$257.2K3. Consulting Fee$105.5K4. Honoraria$60.0K5. Travel and Lodging$32.3K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $605.5K 238
Food and Beverage $257.2K 10,385
Consulting Fee $105.5K 60
Honoraria $60.0K 4
Travel and Lodging $32.3K 146

Recipient Concentration in General Payments

The five largest recipient relationships account for $298,115.44 (28.1%) of $1,060,498.44 in this company's General Payments records across 6,450 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Verrica Pharmaceuticals Inc.

The five named recipients with the highest reported General Payments from this company

Natalia Fontecilla$102.8KLawrence Eichenfield$60.2KPearl Kwong$56.8KRobin Gehris$39.3KAnthony Mancini$39.0K
  1. 1

    Natalia Fontecilla

    $102,843.74 across 66 reported transactions

  2. 2

    Lawrence Eichenfield

    $60,214.65 across 7 reported transactions

  3. 3

    Pearl Kwong

    $56,761.07 across 47 reported transactions

  4. 4

    Robin Gehris

    $39,258.87 across 29 reported transactions

  5. 5

    Anthony Mancini

    $39,037.11 across 17 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $98.72. Average per recipient: $98.73.

Total Amount

$1,069,586.09

Avg per Transaction

$98.72

Avg per Recipient

$98.73

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Verrica Pharmaceuticals Inc. Share

0.0%

#606 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Verrica Pharmaceuticals Inc.

Innovasis Inc

$1.1M 368 recipients

Prytime Medical Devices, Inc.

$1.1M 311 recipients

Grifols Therapeutics LLC

$1.1M 1 recipients

Bionova Medical Inc

$1.1M 0 recipients

ZOLL Circulation Inc

$1.1M 485 recipients

Synergy Products LLC

$1.1M 0 recipients

Frequently Asked Questions

How much did Verrica Pharmaceuticals Inc. pay to physicians and hospitals in 2024? ▾
Verrica Pharmaceuticals Inc. made $1,069,586.09 in payments to physicians and hospitals in Program Year 2024, across 10,835 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Verrica Pharmaceuticals Inc.? ▾
10,833 physicians and teaching hospitals received payments from Verrica Pharmaceuticals Inc. in 2024, averaging $98.73 per recipient.
What types of payments did Verrica Pharmaceuticals Inc. make? ▾
General payments from Verrica Pharmaceuticals Inc. span 5 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Compensation for Services Other Than Consulting" at $605.5K, representing 56.6% of the company's reported total.
How does Verrica Pharmaceuticals Inc. rank among pharmaceutical companies? ▾
By total payment amount, Verrica Pharmaceuticals Inc. sits at #606 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Verrica Pharmaceuticals Inc.? ▾
Verrica Pharmaceuticals Inc.'s 10,835 transactions to 10,833 recipients in 2024 averaged $98.72 per transaction.
Where does the payment data for Verrica Pharmaceuticals Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Verrica Pharmaceuticals Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.